Acelrx Pharmaceuticals reported $-62000 in Gross Profit on Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Acelrx Pharmaceuticals ACRX:US USD -62000 244K
Baxter International BAX:US USD 1.15B 310M
Becton, Dickinson and BDX:US USD 2.08B 9M
Cara Therapeutics CARA:US USD 7.76M 15.24M
Intra Cellular Therapies ITCI:US USD 66.02M 15.09M
Johnson & Johnson JNJ:US USD 15.94B 56M
Pfizer PFE:US USD 16.55B 2.52B
Smiths SMIN:LN GBP 505M 49M
Teva Pharmaceutical TEVA:IT USD 1.71B 118M
Xeris Pharmaceuticals Inc XERS:US USD 24.46M 3.97M